Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

MAZE FY 2022 Earnings — Maze Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

MAZEMaze Therapeutics, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$111M

Net Income

-$115M

EPS (Diluted)

$-2.63

Cash Flow

Operating Cash Flow

-$99M

Free Cash Flow

-$101M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$150M

Total Liabilities

$49M

Stockholders' Equity

$101M

Cash & Equivalents

$100M

← Q3 2023 All Quarters